Status:
COMPLETED
SMART Trial for Buprenorphine-Naloxone Medication Assisted Treatment Adherence
Lead Sponsor:
Karen Derefinko, PhD
Collaborating Sponsors:
University of Memphis
University of New Mexico
Conditions:
Opioid-use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare the effectiveness of two different interventions for medication-assisted treatment (MAT) adherence: Contingency Management (CM) and Brief Motivational Interview...
Detailed Description
The investigators seek to compare the effectiveness of these two different interventions for MAT adherence by first refining and piloting CM and BSM adherence approaches, then conducting a Sequential ...
Eligibility Criteria
Inclusion
- Present with symptoms of Opioid Use Disorder
- Eligible of receipt of buprenorphine-naloxone medication as determined by Study Doctor
- Access to a telephone
Exclusion
- Under 18 years old
- Unable to understand spoken English
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2025
Estimated Enrollment :
332 Patients enrolled
Trial Details
Trial ID
NCT04080180
Start Date
February 1 2022
End Date
February 1 2025
Last Update
February 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Tennessee Health Science Center
Memphis, Tennessee, United States, 38163